drugset / Trial / NCT00262002

Study of the Safety and Immune Response of a Meningococcal Vaccine Administered to Healthy Infants

NCT00262002

Phase 2 Completed 601 enrolled Novartis Vaccines Novartis · collab
RandomizedParallel-groupOpen-labelPrevention

Summary

The purpose of this study is to evaluate the safety, immunogenicity and induction of immune memory after two or three doses of Novartis (Formerly Chiron) Meningococcal ACWY Conjugate Vaccine administered to healthy infants.

Timeline

Start
2004-09
Primary completion
2005-07
Completion
2006-10

Drugs

EvaluationDrugModalityDoseRoute
Subject MenACWY Ad+ Vaccine Intramuscular
Subject MenACWY Ad- Vaccine Intramuscular
Subject MenACWY-PS Vaccine 0.2 unknown
Subject Menjugate Vaccine Intramuscular
Background DTaP-Hib-IPV Vaccine Intramuscular
Background Hepatitis B vaccine Vaccine Intramuscular
Background Measles, Mumps and Rubella vaccine Vaccine
Background Prevnar 13 Vaccine Intramuscular

Indications